investorscraft@gmail.com

Intrinsic ValueISB Corporation (9702.T)

Previous Close¥1,814.00
Intrinsic Value
Upside potential
Previous Close
¥1,814.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

ISB Corporation operates in Japan’s software application sector, specializing in tailored development services for mobile, medical, and in-vehicle applications. The company’s revenue model is anchored in cloud infrastructure construction, system operation, and maintenance, alongside niche offerings like electric locks and entry control systems. Its diversified portfolio includes government and financial sector solutions, positioning it as a versatile player in Japan’s technology landscape. ISB’s focus on high-growth verticals, such as medical and automotive software, enhances its resilience against sector-specific downturns. With a legacy dating back to 1970, the firm combines deep domain expertise with agile development capabilities, catering to both enterprise and specialized industrial clients. Its Tokyo headquarters underscore proximity to key domestic markets, though international expansion remains limited. Competitive differentiation stems from integrated service offerings—spanning design, hosting, and verification—which reduce client dependency on third-party vendors. However, its reliance on Japan’s domestic demand may expose it to regional economic fluctuations.

Revenue Profitability And Efficiency

ISB Corporation reported revenue of ¥33.95 billion for FY2024, with net income of ¥2.03 billion, reflecting a net margin of approximately 6%. Operating cash flow stood at ¥1.88 billion, while capital expenditures were modest at ¥372 million, indicating disciplined reinvestment. The diluted EPS of ¥177.8 underscores steady earnings generation relative to its 11.4 million outstanding shares.

Earnings Power And Capital Efficiency

The company’s earnings power is supported by its diversified service lines, with a beta of 0.328 suggesting lower volatility compared to broader markets. Its capital efficiency is evident in a debt-to-equity ratio of just ¥120 million against ¥8.98 billion in cash, highlighting a conservative balance sheet. Operating cash flow covers interest obligations comfortably, reinforcing financial stability.

Balance Sheet And Financial Health

ISB maintains a robust liquidity position with ¥8.98 billion in cash and equivalents, dwarfing its minimal total debt of ¥120 million. This conservative leverage profile, coupled with positive operating cash flow, ensures ample flexibility for strategic investments or dividend commitments. The absence of significant liabilities underscores a low-risk financial structure.

Growth Trends And Dividend Policy

Growth appears steady, driven by demand for specialized software in regulated sectors like healthcare and transportation. The company’s dividend payout of ¥54 per share signals a shareholder-friendly policy, though reinvestment opportunities in high-margin segments may take precedence. Historical performance suggests a balanced approach between growth and returns.

Valuation And Market Expectations

At a market cap of ¥15.61 billion, ISB trades at a P/E ratio of approximately 7.7x, reflecting modest investor expectations. The low beta implies perceived stability, but limited international exposure may cap premium valuation potential. Market pricing likely discounts Japan’s subdued tech sector growth relative to global peers.

Strategic Advantages And Outlook

ISB’s entrenched position in Japan’s niche software markets provides a defensive moat, though reliance on domestic demand poses concentration risks. Strategic focus on high-value sectors like medical technology could offset macroeconomic headwinds. The outlook remains stable, with opportunities in digital transformation trends, but scalability beyond Japan remains untested.

Sources

Company filings, Tokyo Stock Exchange data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount